We’re incredibly humbled to be named to the Inc. Regionals: Fastest-Growing Companies list —an honor that reflects far more than growth. It reflects belief.
#prodigyserves
https://t.co/lQO22REbNI
Payers now have access to more information than ever before. The limiting factor is rarely data.
It’s knowing what to do next.
Better decisions—not more reports—are what drive outcomes.
That’s where we come in.
→ https://t.co/H9vlsUeOq9
#prodigyserves
Savings look strong above the surface. Specialty sits below it. That’s where the real story lives.
What you see in the reports is only part of the picture. The trend is often below the waterline.
→ https://t.co/H9vlsUeOq9
#prodigyserves
One of the most overlooked drivers of workers’ comp pharmacy costs isn’t utilization—it’s unit cost.
Read more to learn why topical medications remain a high-cost category hiding in plain sight. #ProdigyServes
👉 https://t.co/H9vlsUeOq9
The right medication can’t help if the patient can’t get it.
Access matters.
Timing matters.
Recovery depends on both.
Read more: Why pharmacy barriers continue to impact workers’ comp outcomes. #prodigyserves
https://t.co/XdHr9iX2NW
It’s graduation season, and we are sending our warmest congratulations and best wishes to the PharmD Class of 2026!
Thank you for your hard work, curiosity, and contributions during your time with us. #prodigyserves
This Memorial Day, we pause to honor and remember the brave men and women who made the ultimate sacrifice in service to our country.
Thank you to all who have served and to the families who continue to carry their legacy forward. #prodigyserves#thankyou
We’re bringing PBM transparency to the 25-year workers’ comp conversation.
Join us at the Pennsylvania Workers’ Compensation Conference in Hershey. Stop by Booth 80 and let’s talk #PBM and #transparency in Pennsylvania comp pharmacy. https://t.co/6UY876gx7G #prodigyserves#PAWCC
Payers are drowning in dashboards.
More charts. More visuals. More “insights.”
But reporting volume and actual clarity are not the same thing.
Because better decisions come from better understanding — not just better graphics.
https://t.co/9zg1t6lO0p
#prodigyserves
PTSD in firefighters is no longer being viewed as an invisible consequence of the job.
Important read on where the system is heading.
Read more: https://t.co/XLKr6R6ltm
#prodigyserves
Happy Mother’s Day to all the incredible moms and grandmothers. Thank you for the strength, care, wisdom, and love you bring to your families, workplaces, and communities every single day. Today, we celebrate you. #prodigyserves
In PBM, cost isn’t random—it follows incentives.
Default choices deserve scrutiny. Now more than ever.
What’s been working—and for who?
👉 https://t.co/H9vlsUeOq9
Kicking off RIMS RiskWorld 2026 — connect. cultivate. collaborate.
Excited for great conversations and new connections. If the PBM math matters to you, let’s talk. https://t.co/iyDpalhqgM
More reports don’t create clarity. Reporting has increased—clarity hasn’t.
Noise builds. Utilization reveals the signal. Outcomes tell the full story. Want clarity?
→ https://t.co/H9vlsUeOq9 #prodigyserves
The pipeline doesn’t wait. Neither should your strategy. In case you missed it: 1Q 2026 FDA New Drug Approvals. Today’s pipeline is tomorrow’s cost curve. #prodigyserves
https://t.co/9LwXowBUTB
Most of the time we focus on the injury.
But sometimes, the barrier to return to work isn’t the injury anymore.
It’s the medication.
Sedation. Cognitive slowing. Dizziness.
Read more: https://t.co/yNYcHY7Nod
#prodigyserves
We see it all the time—overly complicated workflows and dashboards, often mistaken for sophistication. It’s not.
👉 If your program feels too complex, ask why.
👉 We’re here to help simplify: https://t.co/9zg1t6lO0p
Muscle relaxants can help in the moment.
What starts as short-term relief can quietly extend into long-term use, bringing sedation, dependency risk, and delayed functional recovery.
Read more: https://t.co/fhkEHIVwVR
#prodigyserves
Workers’ comp can’t afford guesswork—especially in pharmacy. PBMs are under increasing public scrutiny for opaque pricing and misaligned incentives. That conversation is long overdue in comp. This isn’t about promises. It’s about proof. https://t.co/9zg1t6lO0p #prodigyserves